Navigation Links
Rib-X CEO Susan Froshauer, PhD, Honored by The Connecticut Women's Hall of Fame
Date:10/31/2008

NEW HAVEN, Conn., Oct. 31 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery, development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, today announced that President and CEO, Susan Froshauer, PhD, was honored last night by The Connecticut Women's Hall of Fame at their 15th Annual Gala & Induction Ceremony. As part of this year's event, a group of 15 women were recognized as members of the "New Century of Women in Science" along with four high school and college age students for their innovation and commitment to the advancement of the scientific and engineering fields.

This year's inductees included Nobel Prize Winner Barbara McClintock, PhD, world-renowned Yale University neuroscientist Patricia Goldman-Rakic, PhD, Yale University Sterling Professor of Molecular Biophysics Joan Steitz, PhD, and leading cell biologist Jewel Plummer Cobb, PhD. Previous inductees include Florence Wald, the founder of hospice care in the U.S., Emeline Roberts Jones, DDS, the first female dentist in the U.S., Hellen Keller and Katharine Hepburn.

"I am humbled to be a part of this collective group of women pioneers and to have been recognized by my peers," said Susan Froshauer, PhD, President and CEO of Rib-X Pharmaceuticals. "By continuing to shine a light on the amazing contributions of young Connecticut women, The Connecticut Women's Hall of Fame is ensuring that these women are recognized for their impressive achievements at a local level."

About Rib-X Pharmaceuticals, Inc.

Rib-X Pharmaceuticals, Inc. is a product-driven small molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. The Company's underlying drug discovery engine capitalizes on its proprietary high-resolution crystal structure of the ribosome, which performs an essential role in protein synthesis. Many known, commercially valuable antibiotics exert their effects by binding to the bacterial ribosome. The Company's integrated research strategy, which combines state-of-the-art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative intelligent engine has yielded several distinctive new antibiotics that can be used for the treatment of either community- or hospital-acquired infections. Radezolid (RX-1741), an oxazolidinone, is an oral/IV agent for treatment of serious Gram-positive infections. The Rx-04 discovery program is developing novel classes of antibiotics active against multi-drug resistant Gram-negative bacteria and the Rx-02 discovery program is focused on developing an IV/oral macrolide active against methicillin-resistant S. aureus, multidrug-resistant Streptococus pneumonia and S. pyogenes. Additionally, Rib-X is developing delafloxacin, (RX-3341), an anionic fluoroquinolone active against a broad spectrum of bacteria, including quinolone-resistant Gram-positive bacteria and MRSA. Both radezolid and delafloxacin are currently in Phase 2 clinical trials.

For more information on the Rib-X mission and the pipeline, please visit the Company website at http://www.rib-x.com.

About The Connecticut Women's Hall of Fame

The Connecticut Women's Hall of Fame is an educational outreach organization whose mission is to honor publicly the achievement of Connecticut women, preserve their stories, educate the public and inspire the continued achievements of women and girls. Founded in 1994 in Hartford, Connecticut, the Hall fills the void that traditional curricula still fail to address and today stands as the state's premier source for women's history with over 85 Inductees. These women's lives and accomplishments are celebrated and documented through a wide spectrum of innovative statewide programs offered free of charge to Connecticut citizens. The CWHF Website, which is an educational tool receiving more than 100,000 individual visits each year, attracts international, national and local researchers, teachers and students. For more information please visit http://www.cwhf.org.


'/>"/>
SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Susan Lark, MD Says "Volunteer" Your Way to Good Health this Holiday Season
2. Susan G. Komen Breast Cancer Foundation awards grant for imaging-agent research
3. Susan Lark, MD Offers 5 Tips for Managing Stress During Tough Economic Times
4. Susan G. Komen for the Cure(R) Strengthens Global Mission With Addition of Vice President, International
5. DownEast Outfitters Supports Susan G. Komen for the Cure(R) with Breast Cancer Awareness Event and Donation
6. Susan G. Komen for the Cure(R) Advocacy Alliance Unveils New I Vote for the Cure(R) Web Video
7. Susan Lark, MD Develops a Powerful ORAC Drink Packed with the Antioxidant Power of Nine Fruits
8. New Specialty Hospital Dedicated in Ghana is Key Component of Susan G. Komen for the Cure(R)s Debut in Africa
9. Stronger Together: The Mohawk Group Supports Breast Cancer Awareness with T-Shirts Designed by Todd Oldham, Proceeds to Benefit Susan G. Komen
10. Supporting Susan G. Komen for the Cure(R) During National Breast Cancer Awareness Month
11. Purina(R) Cat Chow(R) Brand Cat Food Partners With Susan G. Komen for the Cure(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Calif. , June 24, 2016  American Respiratory Labs (ARL), ... is now able to perform sophisticated lung assessments in patients, homes, ... , Inc. Patients are no longer limited to ... EasyOne PRO ® , ARL patients like Jeanne R. of ... in the comfort of her own home. ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
Breaking Medicine Technology: